Complete brain activity map revealed for the first time
On Sept. 3, 2025, The International Brain Laboratory (IBL) researchers published their findings today in two papers in Nature, revealing…
Golden Goose Award Honors Federally Funded Breakthroughs in Cancer Treatments and Disease Diagnostics
On Sept. 3, 2025, The Golden Goose Award, which spotlights obscure, silly sounding or odd fundamental discovery research that…
C2N Diagnostics Expands St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
Avian flu found in North Dakota, South Dakota turkeys
On Sept. 3, 2025, Avian flu has hit turkey farms in North Dakota and South Dakota, the first…
Navy base in Italy reports case of West Nile virus
On Sept. 3, 2025, Navy hospital here is warning people to take precautions against West Nile virus after…
Amgen to Invest $600 Million in New State-of-the-Art Center for Science Innovation at U.S. Headquarters
On Sept. 2, 2025, Amgen announced plans to invest more than $600 million in a new, state-of-the-art center…
OMass Therapeutics announces Collaboration and License Agreement for IBD with Genentech Worth $420 Million
On Sept. 2, 2025, OMass Therapeutics announces an exclusive collaboration and license agreement with Genentech, a member of…
Biotechnology | NIH | Vaccine
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS®, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
On Sept. 2, 2025, Emergent BioSolutions announced it had received a $30 million contract modification from the Biomedical Advanced…
Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
Biotechnology | Diagnostics | Disease | Neurology | Oncology
New genetic biomarker flags aggressive brain tumors
On Sept. 1, 2025, a multi-institutional study suggests that typically classifiication of meningiomas by appearances may be deceiving…
Duke Receives $69 Million NIH Grant to Translate Science into Better Health for All
On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million…
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Influenza | Vaccine
MIT researchers develop AI tool to improve flu vaccine strain selection
On Aug. 28, 2025, scientists at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Abdul…
Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight Loss
On Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…
Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…
researchers solve 1,500-year-old mystery: The bacterium behind the first pandemic
On Aug. 27, 2025, for the first time an interdisciplinary team at the University of South Florida (USF)…
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64
On Aug. 27, 2025, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) has approved the…
Mexico reports 53% increase in flesh-eating screwworm cases since July
On Aug. 27, 2025, Mexico has recorded 5,086 cases of flesh-eating screwworm in animals as of August 17,…
Artificial Intelligence | Biotechnology | Genomics | Nanotechnology | Neurology | Non-Profit Research
Microsoft co-founder Paul Allen’s final act: New $3.1B foundation bets big on science and tech
On Aug. 27, 2025, a new fun created by Allen’s estate under the late Microsoft co-founder’s instructions, was…
new resource, MacroMap, provides a rich dataset that researchers can use to explore genetic mechanisms behind complex diseases
On Aug. 27, 2025, scientists from the Wellcome Sanger Institute reveal insights into how our genes influence the…
Aedes aegypti non-native mosquito detected in Oregon
On Aug. 26, 2025, health officials in Ashland, Oregon reported that six Aedes aegypti mosquitoes were found in…
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
On Aug. 26, 2025, Osivax announced it has secured $19.5 million in funding from the Biomedical Advanced Research…
Georgia State Scientists Revive Ancient Gene to Target Gout, Fatty Liver Disease
On Aug. 26, 2025, scientists at Georgia State University (GSU) announced a study published in Scientific Reports that…
Valneva shares tumble after suspension of U.S. chikungunya vaccine license
On Aug. 25, 2025, shares of French drugmaker Valneva slumped more than 20% after the U.S. Food and…
AbbVie to Acquire Gilgamesh Pharma’s Investigational Therapy for Major Depressive Disorder for $1.2 Billion
On Aug. 25, 2025, AbbVie and Gilgamesh Pharmaceuticals announced a definitive agreement under which AbbVie will acquire Gilgamesh’s…
In a first, pig lung survives and functions—briefly—in a person
On Aug. 25, 2025, in a small step forward for the long-struggling field of xenotransplantation, surgeons in China…
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
On Aug. 25, 2025, Genentech, a member of the Roche Group broke ground on its newest U.S. manufacturing site…
Tuskegee University breaks ground on $14 Million game-changing genomic research center
On Aug. 25, 2025, Tuskegee University cancer researchers gathered under two green tents to celebrate a day they…
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
Biotechnology | CDC | Diagnostics | Infectious Disease | NIH | Therapeutics | USDA
U.S. confirms nation’s first travel-associated human screwworm case connected to Central American outbreak
On Aug. 24, 2025, the U.S. Department of Health and Human Services reported the first human case in…